Walsh & Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.28K Buy
+150
New +$3.99K ﹤0.01% 226
2026
Q2
– Sell
-11
Closed -$309 – 280
2026
Q1
$309 Buy
+11
New +$293 ﹤0.01% 250

Other funds holding PFE

Walsh & Associates's PFE Position: Q3 2026 in Review

Walsh & Associates opened a new position in Pfizer (PFE) in Q3 2026: 150 shares worth $4.28K. The stake represents ﹤0.01% of the portfolio and ranks #226 among its holdings. This is a return to the name: Walsh & Associates previously reported a position in PFE as recently as Q1 2026.

Walsh & Associates first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Walsh & Associates held 150 shares of Pfizer worth $4.28K as of Q3 2026.
  • Pfizer was a new Walsh & Associates position in Q3 2026.
  • Pfizer made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #226 holding.
  • Walsh & Associates first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.